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Mutant SOD1 detoxification mechanisms in intact
single cells
S Ganesan1,2, G Rohde2,3, K Eckermann2,3, K Sroka2,3, MKE Schaefer4, CP Dohm2,3, P Kermer2,3, G Haase4, F Wouters*,1,2, M Ba¨hr2,3
and JH Weishaupt*,2,3
Mutant superoxide dismutase 1 (mtSOD1) causes dominantly inherited amyotrophic lateral sclerosis (ALS). The mechanism for
mtSOD1 toxicity remains unknown. Two main hypotheses are the impairment of proteasomal function and chaperone depletion
by misfolded mtSOD1. Here, we employed FRET/FLIM and biosensor imaging to quantitatively localize ubiquitination, as well as
chaperone binding of mtSOD1, and to assess their effect on proteasomal and protein folding activities. We found large
differences in ubiquitination and chaperone interaction levels for wild-type (wt) SOD1 versus mtSOD1 in intact single cells.
Moreover, SOD1 ubiquitination levels differ between proteasomal structures and cytoplasmic material. Hsp70 binding and
ubiquitination of wt and mtSOD1 species are highly correlated, demonstrating the coupled upregulation of both cellular
detoxification mechanisms upon mtSOD1 expression. Biosensor imaging in single cells revealed that mtSOD1 expression alters
cellular protein folding activity but not proteasomal function in the neuronal cell line examined. Our results provide the first cell-
by-cell-analysis of SOD1 ubiquitination and chaperone interaction. Moreover, our study opens new methodological avenues for
cell biological research on ALS.
Cell Death and Differentiation advance online publication, 9 November 2007; doi:10.1038/sj.cdd.4402262
Amyotrophic lateral sclerosis (ALS) is a progressive fatal
neurodegenerative disease caused by the selective loss of
motoneurons.1 While ALS mostly occurs sporadically, 5–10%
of cases are hereditary. About 20% of familial and few
sporadic cases show point or frameshift mutations within the
superoxide dismutase 1 (SOD1) gene.2 The principle under-
lying mutant superoxide dismutase 1 (mtSOD1) toxicity
seems to be a toxic gain – rather than loss – of function,
since symptomatic mtSOD1-transgenic mice still express
wild-type (wt), SOD1, some SOD1 mutants retain their
enzymatic activity,2,3 and neither knockout of endogenous
SOD1 nor transgenic overexpression of wtSOD1 affect the
course of disease in mtSOD1-transgenic mice.4 Nonetheless,
the downstream events in mtSOD1-mediated motoneuron
death have not yet been resolved, although several hypoth-
eses have been proposed that are based on properties that
are specific for mtSOD1: altered protein folding, decreased
solubility, and the propensity to form cytoplasmic aggre-
gates.5–10One of the major hypotheses states that misfolded
mtSOD1, through binding, depletes neuroprotective chaper-
ones.5–7 Accordingly, recombinant mtSOD1 inhibited chaper-
one activity in vitro.11 Moreover, expression of Hsp70, Hsp27,
or Hsp40 decreased aggregation of mtSOD1 and protected
against mtSOD1 toxicity in cell lines and primary moto-
neurons.6,12 However, overexpression of Hsp70 alone did not
improve motoneuron survival in mtSOD1-transgenic mice.13
This is possibly explained by a requirement, in vivo, for
correction of further cellular functions or the combined action
of different chaperones in the prevention of motoneuron cell
death. Indeed, arimoclomol treatment, known to upregulate
both Hsp70 and Hsp90 in the spinal cord, extended the
lifespan of SOD1G93A-transgenic mice.14
Alternatively, proteasomal overload and dysfunction
caused by the expression of aberrantly folded SOD1 might
contribute to motoneuronal demise.15 mtSOD1 is polyubiqui-
tinated, can be degraded by the proteasome,16–18 and
proteasomal activity was decreased in the lumbar spinal cord
of SOD1G93A-transgenic mice.19
SOD1 protein interactions, SOD1 ubiquitination, and
altered cellular chaperone or proteasomal activities have
been investigated previously before using biochemical assays
on homogenized cells or subcellular fractions.5,11,19 A major
drawback of these approaches is their disruptive nature and
the lack of spatial information.
We made use of Fo¨rster resonance energy transfer (FRET),
measured by fluorescence lifetime imaging (FLIM) to explore
the mechanisms of mtSOD1 turnover and toxicity. The
intrinsically quantitative nature of FLIM measurements al-
lowed us to perform analytical biochemical measurements
inside single cells. Using a recently developed FRET assay
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with improved sensitivity,20 we visualized SOD1 ubiquitination
and chaperone interaction in intact single cells, and uncov-
ered profound differences between wild-type and mtSOD1.
Using innovative fluorescence-imaging-based biosensors,21
we also demonstrate in a cell-by-cell investigation differences
with regard to chaperone activity between wt and mtSOD1-
transfected cells. Our findings substantially advance the
understanding of cellular alterations by mtSOD1 and provide
support for the involvement of altered chaperone function,
rather than proteasomal deficits, in the mechanism of
mtSOD1 toxicity.
Results
FRET/FLIM-based measurement of SOD1 ubiquitination
using the REACh FRET acceptor. A recently developed
FRET/FLIM protocol using a mutant non-fluorescent
enhanced yellow fluorescent protein (EYFP) called
resonance energy-accepting chromoprotein (REACh)
conjugated to ubiquitin as FRET acceptor, and wt/mtSOD-
EGFP as donor20; see also Materials and Methods) was
used to study SOD1 ubiquitination distributions in intact
neuronal cells. The spectral advantages of this new FRET
pair over commonly used pairs render it highly efficient for
the detection of FRET.
We used neuronal CSM14.1 cells for our experiments
because of their robust and reproducible transfection effi-
ciency that we require for our FLIM measurements and
chaperone activity biosensor (see below). Importantly, their
abundant cytoplasm allows detailed observation of the
subcellular FRET distribution.
We verified that the EGFP tag on SOD1 does not
profoundly alter the normal properties and maturation of the
protein. To this end, we used an in-gel enzymatic SOD1
activity assay.22 We show that EGFP-SOD1 fusion proteins
(wt and the ‘wt-like’ G93A mutant) form dimers and exhibit the
expected superoxide dismutase activity (Figure 1a and b). In
contrast to EGFP-SOD1G93A, enzymatic activity was lost by
EGFP-SOD1G85R, as observed before for the untagged
SOD1G85R mutant.23 The finding that our SOD1 fusion
proteins still dimerize and – if not abolished by the respective
mutation – exhibit normal dismutase activity, indicates that the
EGFP tag does not preclude proper maturation, dimerization
and copper loading of SOD1. This was further confirmed by
the presence of the intramolecular disulfide bond in EGFP-
SOD1 fusion proteins that is essential for activity and stability
(Figure 1c). The copper chaperone for SOD1 (CCS) both
inserts the catalytic copper cofactor and catalyzes the
formation of the disulfide bond,24 thus also indicating proper
recognition and processing of the protein by the CCS.
Cells expressing only EGFP-SOD1 exhibited typical EGFP
lifetimes, independent of fusion of wt or mtSOD1 (2.0–2.2 ns;
Figure 2a–c). Moreover, there is no evidence for EGFP
ubiquitination, as fluorescence lifetimes in EGFP expressing
cells are unaffected by coexpression of REACh-ubiquitin
(Figure 2d).
Coexpression of wt or mutant EGFP-SOD1 with REACh-
ubiquitin resulted in a strongly reduced lifetime. In some
cytoplasmic areas, the lifetime dropped to approximately
1.2 ns (Figure 2e–j), indicating high FRET and a direct
interaction of SOD1 with ubiquitin.
The extent and distribution of ubiquitination was clearly
different between EGFP-fused mtSOD1 and wtSOD1. While
fluorescence lifetime values only moderately decreased for
EGFP-SOD1wt (Figure 2e and f), they were markedly
decreased for EGFP-mtSOD1 (Figure 2g–j) with higher
ubiquitination levels for SOD1G85R (Figure 1g and h) than for
SOD1G93A (Figure 2i and j). Statistical analysis of cumulative
fluorescence lifetime histograms (Figure 2k) confirmed the
statistical significance of the differences (Figure 2l).
Figure 1 EGFP-SOD1 fusion proteins dimerize, are enzymatically active and
form an intramolecular disulfide bond. The Western blot in (a) shows expression of
EGFP-SOD1 fusion proteins in CSM14.1 cells 18 h after transfection. A 20-mg
weight of protein lysate was loaded per lane and separated on denaturing SDS gel.
Monomeric EGFP-SOD1 and endogenous wtSOD1 are stained using an anti-SOD1
primary antibody. (b) Shows SOD1 in the in-gel-zymography of lysates from EGFP-
SOD1-transfected CSM14.1 cells (20 mg per lane). A 4-mg weight of human
wtSOD1 protein purified from erythrocytes was loaded as a positive control. Protein
samples were separated on a non-denaturing polyacrylamide gel and stained for
dismutase activity. Three distinct bands of SOD1 activity are observed in samples
from EGFP-SOD1wt- and EGFP-SOD1G93A-transfected cells, representing the
dimers of endogenous untagged SOD1, EGFP-SOD1 dimers, and the respective
heterodimers. In contrast to the ‘wt-like’ SOD1G93A, in cells transfected with the
dismutase-dead mtSOD1G85R,23 only endogenous SOD1wt activity could be
detected. CON: untransfected control cells. The disulfide assay in (c) demonstrates
efficient formation of the conserved intramolecular SOD1 disulfide bond that is
catalyzed by CCS. AMS reacts with the two reduced thiol groups in SOD1 not
involved in disulfide bond formation to (AMS)2-EGFP-SOD1, while the two other
thiol groups form a disulfide bond and are not AMS reactive. This leads to a mobility
shift on a Western blot using a denaturing gradient gel and an anti-SOD1 primary
antibody (see also Materials and Methods section). Treatment with DTT for 1 h at
371C reduces the disulfide bond, making two additional thiol rests available for
reaction with AMS, as shown by a further mobility shift due to formation of (AMS)4-
EGFP-SOD1
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Spots of high FRET were observed perinuclearly, strongly
suggestive of proteasomes. This most likely reflects the
dynamic accumulation of ubiquitinated material in the turnover
of EGFP-SOD1wt due to protein overexpression (Figure 2e
and f). The ubiquitination levels of SOD1G93A and SOD1G85R
in the proteasome structures were significantly higher than for
SOD1wt (Figure 2g–i; quantitation in Figure 3). Surprisingly,
while SOD1G85R showed a higher degree of overall ubiquiti-
nation than the SOD1G93A, the degree of ubiquitination was
identical for both mutants in proteasomal areas (Figure 3),
suggesting their maximal absolute ubiquitination.
We also detected differences in the spatial distribution of
SOD1G85R and SOD1G93A ubiquitination: most (75%) EGFP-
SOD1G93A cells displayed the shortest lifetime (i.e., highest
ubiquitination) in cytoplasmic aggregates (Figure 2i and j). In
contrast, the same fraction of EGFP-SOD1G85R cells have
higher ubiquitination outside aggregates, and reached max-
imum levels in the cell periphery where only non-aggregated,
most likely soluble, EGFP-SOD1G85R is found (Figure 2g and
h). In fact, close-to-normal lifetimes were often observed
inside large SOD1G85R aggregates (Figure 2g and h). No
SOD1 ubiquitination was observed in nuclear regions.
Quantification of proteasome function in single cells
expressing SOD1. We confirmed that CSM14.1 cells are
susceptible to mtSOD1 toxicity (Supplementary Figure) as
with other neuronal cell types.12,25 The increased and
spatially distinct ubiquitination of EGFP-mtSOD1 prompted
us to test the proteasomal overload hypothesis as a mtSOD1
toxicity mechanism. In order to find evidence for altered
proteasome function in intact single cells expressing
mtSOD1, we utilized a destabilized ECFP containing a
PEST sequence (ECFP-PEST) for degradation targeting
and, consequently, rapid turnover (t1/2¼72 h26).
Transfection of ECFP-PEST results in negligible steady-
state levels and only faint ECFP fluorescence, unless
proteasomal degradation is impaired26; Figure 4a and b). A
concentration reference was provided by coexpression of
(non-destabilized) EYFP to standardize ECFP-PEST
fluorescence against concentration differences. Division of
ECFP by EYFP fluorescence gives the proteasomal stability
metric. Treatment with the proteasome inhibitor lactacystin at
a concentration of 20mM for 24 h resulted in a B6-fold
reduction in proteasomal activity, confirming the validity of
our assay (Figure 4a and b). Quantification of ECFP-PEST
stability did not reveal any changes in proteasomal activity
between cells transfected with control vector, wt or mtSOD1
for 24 h (data not shown) or even 48 h (Figure 4a and b).
Interaction of SOD1 with Hsp70. In the absence of
proteasomal dysfunction, chaperone depletion by mtSOD1
remains as an alternative explanation for the impairment of
neuronal viability. We employed the FRET/FLIM technique to
study the interaction of SOD1 (wt and mutant) with the Hsp70
chaperone in single cells. Again, EGFP-SOD1 served as
FRET donor, and Hsp70 was fused to REACh acceptor
(REACh-Hsp70). As before, the expected unperturbed EGFP
lifetimes were obtained for wt and mtSOD1 fusions (Figure
5a–c). In contrast, coexpression of REACh-Hsp70 with
EGFP-SOD1wt mildly reduced the EGFP lifetime (to about
1.7 ns; Figure 5d), indicating that SOD1wt interacts with
Hsp70. This interaction was clearly increased for EGFP-
SOD1G85R and EGFP-SOD1G93A, as shorter lifetimes were
measured, approaching 1.2 ns in some subcellular areas
(Figure 5e and f). Figure 5g and h show the respective
quantitative analysis, with SOD1G85R interacting more
intensively than SOD1G93A.
Compared with the ubiquitination of SOD1 described
above, the distribution of SOD1/Hsp70 interactions appeared
more homogeneously, without appreciable differences be-
tween aggregates and cytoplasmic, soluble EGFP-SOD1.
The shortest fluorescence lifetimes were observed in the cell
periphery.
Even though EGFP-SOD1wt clearly entered the nucleus, no
interaction with Hsp70 was measured in this compartment,
providing an intrinsic biological control for the specificity and
relevance of the found interactions. Notably, coexpression of
REACH-Hsp70 altered the appearance of EGFP-mtSOD1
(right panels in Figure 5e and f); the mtSOD1 accumulations
appeared less confined and with smoother borders (compare
also with Figure 2a–c). Hsp70 overexpression also resulted in
a lower density of EGFP-mtSOD1 aggregates, suggesting
that the chaperone improved the solubility of the protein.
Hsp70 interaction of SOD1 mutants correlates with
ubiquitination. Quantitative cell-by-cell FLIM analysis of
ubiquitination and Hsp70 binding of wt and mtSOD1 allowed
us to correlate both detoxification mechanisms. Correlation
of the data sets from wtSOD1, G93A, and G85R mtSOD1
revealed a close relationship (r¼ 0.97; Figure 6) between
both events. It thus appears that the increased cellular
toxicity of SOD1 species increases both ubiquitination and
Hsp70 binding in parallel, strongly suggesting that both
detoxification pathways are upregulated in an attempt to
reduce the amount of insoluble, aggregation-prone, toxic
SOD1 protein.
Functional effect of mtSOD1 on cellular chaperone
activity. As we found increased chaperone binding by
mtSOD1, we investigated its functional influence for cellular
chaperone activity in the single cell using a recently
developed fluorescence imaging-based, broad-specificity
chaperone activity biosensor.21 This biosensor consists of a
folding-impaired mutant of yellow fluorescent protein
(cdYFP) tagged with an HA epitope. Its folding and
maturation that is necessary for the generation of the
chromophore is impaired and thus only minor fluorescence
is generated. However, in cells experiencing increased
chaperone activity, cdYFP conformation can recover to
yield fluorescence similar to native YFP. Expression levels
of the cdYFP reporter are normalized to the inert HA
immunostaining signal (see also Materials and Methods).
The chaperone activity in the cytosol increased upon
coexpression of wtSOD1, approaching the levels reached
by ECFP-Hsp70 overexpression, which was used as a
positive control (Figure 7a–d).
Coexpression of SOD1G85R also induced chaperone
activity, but significantly less than with wtSOD1 (Figure 7a–
d). Chaperone activity in SOD1G93A-expressing cells even
FRET/FLIM studies on mutant SOD1
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dropped below baseline values obtained in control cells
expressing only cdYFP (Figure 7a–d).
Discussion
With the use of genetically encoded optical biosensors for
proteasomal and chaperone activity, Hsp70/SOD1 interac-
tion, and SOD1 ubiquitination, we investigated the cellular
detoxification pathways that are elicited by the expression of
mtSOD1. We demonstrate profound differences in chaperone
binding and activation, as well as ubiquitination between wt
and ALS-associated mtSOD1.
SOD1 ubiquitination was quantitatively imaged in intact
single cells using the non-fluorescent REACh acceptor for
FRET with EGFP.20 In contrast to biochemical methods, our
FLIM/FRET measurements allow the spatial quantification of
FRET/FLIM studies on mutant SOD1
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SOD1 ubiquitination and its heterogeneity between cells.
Overall, mtSOD1 ubiquitination is enhanced compared with
wtSOD1. Also in proteasomal areas, mtSOD1 ubiquitination is
clearly higher than for wtSOD1. However, in contrast to
cytoplasmic regions, levels are identical for SOD1G93A and
SOD1G85R, suggesting increased but saturated ubiquitination
levels for the mutant species in proteasomal areas. This either
reflects more extensive polyubiquitination (i.e., decreased
deubiquitination) or additional ‘pathological’ ubiquitination
sites in mtSOD1.
Our results on SOD1 ubiquitination are in agreement with
strong biochemical evidence that SOD1 is at least in part
degraded by an ubiquitin-dependent proteasomal path-
way.16–18 Moreover, the discovery of ubiquitin ligases
specifically ubiquitinating mtSOD127,28 may relate to our
observation of enhanced ubiquitination of mtSOD1. Never-
theless, it is likely that additional degradation pathways other
than ubiquitin–proteasomal degradation participate in SOD1
turnover. For example, a recent paper shows that macro-
autophagy and proteasomal degradation contribute approxi-
mately equally to SOD1 clearance.16 Furthermore, results
from cell-free assays suggest that the 20S proteasome
preferentially degrades metal-depleted, monomeric mtSOD1
also in a ubiquitin-independent manner.29 Whether the
holoenzyme or the demetallated, S–S bond reduced form of
SOD1 is preferentially ubiquitinated and targeted for degrada-
tion can, as yet, not be determined by our approach.
Accumulating evidence suggests a triage decision in
handling toxic misfolded proteins in aggregopathies; proteins
are either (1) successfully refolded, (2) stored in aggregates,
Figure 2 Quantification and localization of SOD1 ubiquitination in intact neuronal cells measured by FLIM. (a–j) Representative fluorescence lifetime images (fluorescence
lifetime in color coding, left panels) and distribution of the EGFP donor constructs (EGFP intensity pictures, right panels). The scale bar in (a) indicates the color-coding of
fluorescence lifetime values. Warmer colors indicate lower lifetimes, that is, higher FRET efficiencies, and cooler colors indicate higher lifetimes, that is, lower FRET
efficiencies. (a–d) Typical EGFP fluorescence lifetimes (1.8–2 ns) were observed in CSM14.1 cells expressing the EGFP-SOD1 donor constructs only (a–c), or in cells
coexpressing EGFP and REACH-ubiquitin (d). Coexpression of EGFP-SOD1 constructs with REACh-ubiquitin resulted in strongly shortened lifetimes (e–j), with a regionally
heterogenous distribution. (f, h, j) These panels show the magnifications of the representative cells shown in (e, g, i). (k) Shows the cumulative histograms of FRET efficiencies
of wt and mutant EGFP-SOD1 when coexpressed with REACH-ubiquitin. Lifetime values were converted to FRET efficiencies by comparison to the EGFP lifetime of control
cells expressing EGFP-SOD1wt in the absence of REACh-labeled interaction partner (REACH-ubiquitin). (l) Shows the quantification of histograms shown in (k). The
cumulative distribution of the FRET efficiencies of control cells expressing EGFP-SOD1 without coexpression of the REACh-labeled ubiquitin were fitted with a Gaussian
function to obtain the average plus three times standard deviation value (3s). Any values exceeding this threshold thus represent increases that deviate from the control
situation. The probability of obtaining significant FRET was derived for each cell by integration of the normalized FRET distribution histograms above the 3s threshold (l).
CSM14.1 cells (from three independent experiments) were imaged 18 h after transfection with the respective expression constructs. Data sets are presented as
mean7S.E.M. Statistical analysis was performed by ANOVA and Tukey’s post hoc analysis. PDF, probability distribution function; Ubq, ubiquitin
Figure 3 Cumulative histograms of wt and mutant EGFP-SOD1/REACH-
ubiquitin FRET efficiencies in proteasomal areas. Lifetime values were converted to
FRET efficiencies by comparison to the EGFP lifetime cells expressing EGFP-
SOD1 in the absence of the labeled interaction partner REACH-ubiquitin (control).
The cumulative FRET efficiencies (x-axis) for the different proteins are presented as
in Figure 2. CSM14.1 cells were imaged 18 h after transfection with the respective
expression constructs. Proteasomes were defined as perinuclear punctate
structures with high FRET between EGFP-SOD1 (wt, G85R, and G93A mutants)
and REACh-ubiquitin and were segmented for processing by thresholding of the
FRET efficiencies. Data sets are presented as mean7S.E.M. Statistical analysis
was performed by ANOVA and Tukey’s post hoc analysis. PDF, probability
distribution function
Figure 4 Overexpression of SOD1 does not impair proteasomal function in
CSM14.1 cells. The proteasomal substrate destabilized enhanced cyan fluorescent
protein, containing a PEST amino-acid sequence (ECFP-PEST) that targets the
ECFP protein for degradation, was used to measure proteasomal function in
neuronal CSM14.1 cells by relating its fluorescence (Bconcentration) to
coexpressed EYFP. ECFP-PEST/YFP ratios (i.e., normalized ECFP fluorescence
intensity) during coexpression of the respective SOD1 construct, or treatment with
lactacystin (20mM for 24 h) as a positive control, are indicated in (a) (color coded as
indicated by the scale bar). (b) Shows the cumulative histograms summarizing data
from 8–12 cells per condition, showing that SOD1 overexpression does not change
ECFP-PEST levels, which, however, are greatly enhanced by lactacystin. Values
are normalized to the control situation without expression of SOD1 protein
(transfection of empty vector). The expression of the respective SOD1 proteins was
verified by immunostaining of the myc epitope tag contained in the constructs (Cy5-
coupled secondary antibody) for each cell included in the analysis. PDF, probability
distribution function; Lacta, lactacystin
FRET/FLIM studies on mutant SOD1
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or (3) targeted for proteasomal degradation or other degrada-
tion pathways (for review see reference McClellan et al.7). An
imbalance between refolding and degradation may constitute
an early event in cellular death, especially in neurodegenera-
tive diseases where a number of proteins functionally link
protein folding to proteasomal function. The close correlation
between SOD1 ubiquitination and Hsp70 binding supports
their causative interaction and parallel induction. Using the
G85R and G93A SOD1 mutants, we exemplify species with
preserved (SOD1G93A) or impaired (SOD1G85R) enzymatic
activity, and differences in the degree of protein misfolding
and stability.2,3 In contrast to the cytoplasmic distribution of
ubiquitinated SOD1G85R, ubiquitinated SOD1G93A was en-
riched in SOD1 aggregates. We propose that these distinct
ubiquitination patterns might explain their different toxicity and
histopathology.9,10
Despite the observed increased ubiquitination, mtSOD1 did
not impair proteasomal function as measured by the steady-
state levels of destabilized ECFP. In contrast, others could
detect proteasomal impairment using fluorogenic proteolysis
substrates in vitro.17,19 Our approach represents a global
proteasomal measurement that may miss subtle changes in
the subsets of proteasomal activities. On the other hand,
biochemical methods estimate proteasomal function in
protein lysates far from the cellular physiological conditions.
Moreover, a presymptomatic decrease in proteasomal activity
was detected in the lumbar but not cervical spinal cord of
SOD1G93A transgenic mice.19 Thus, although our findings
show that protein folding and the ubiquitination machinery are
involved in the cellular response to mtSOD1, we could not
substantiate the hypothesis of ‘proteasomal overload’ as a
main contributor to toxicity. This could be explained by the
occurrence of (mono-) ubiquitination, which does not always
result in proteasomal degradation, since our assay does
not distinguish between mono- and polyubiquitination.
Moreover, as outlined above, additional pathways besides
Figure 5 Quantification and localization of the interaction between SOD1 and Hsp70 in intact neuronal cells by FLIM. (a–f) Representative fluorescence lifetime images
(fluorescence lifetime color coded, left panels) and distribution of the EGFP donor constructs (EGFP intensity pictures, right panels). The scale bar in (a) indicates the color-
coding of fluorescence lifetime values. (a–c) Typical EGFP fluorescence lifetimes were observed in CSM14.1 cells expressing only the EGFP-SOD1 donor constructs.
Coexpression of wt EGFP-SOD1 constructs with Hsp70-REACh resulted in mildly reduced lifetime values (d), while strongly enhanced FRET was observed when Hsp70-
REACh was coexpressed with mutant EGFP-SOD1 constructs (e, f). (g) Shows the cumulative histograms of FRET efficiencies; panel (h) provides the respective quantitative
analysis of the histograms as in Figure 2l and described in the Materials and Methods section. CSM14.1 cells were imaged 18 h after transfection with the respective
expression constructs. Data sets are presented as mean7S.E.M. Statistical analysis was performed by ANOVA and Tukey’s post hoc analysis. PDF, probability distribution
function
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ubiquitin-dependent proteasomal degradation may contribute
to SOD1 degradation, possibly enabling the cell to cope with
an increased burden of misfolded SOD1 targeted for
degradation.
Rather, we found evidence in favor of the depletion of
cellular chaperones by mtSOD1, which was suggested
before.6,11 Shielding of toxic misfolded proteins by chaperone
binding appears to be a cellular coping mechanism, which
might fail when critical amounts of aggregation-prone proteins
accumulate, specifically in neurons that do not ‘dilute’ toxic
proteins during cell division. Hsp70 was recently shown to be
included in a-synuclein aggregates.30 This points to the
possibility of cellular chaperone trapping during their futile
attempt to dissolve a-synuclein aggregates or to prevent their
formation. The growing aggregate surface is shielded and
rendered physiologically inert by chaperones, at the same
time depleting the cells from their protective and physiological
functions. In our case, a similar mechanism appears to be at
work; chaperones engage in a ‘deadly embrace’ with mtSOD1
and their depletion leaves the toxic insult uncompensated,
leading to cellular death. However, we could show that SOD1/
Hsp70 interaction primarily occurred outside aggregates, in
accordance with the recently reported transient nature of
Hsp70 interaction with aggregated mtSOD1.8 Hsp70 and
other chaperones may thus be predominantly sequestered by
mono- or oligomeric SOD1 species that are still soluble, rather
than being trapped in ‘end stage’ SOD1 aggregates.
The increased binding of Hsp70 to mtSOD1 versus
wtSOD1 implicates Hsp70 as a critical component in toxicity.
However, as our chaperone biosensor does not distinguish
between different chaperones, other chaperones in addition to
Hsp70 are likely involved.
A chaperone activity-enhancing property of wtSOD1 has
not been described before, but is in line with its general
protective role. It remains to be determined whether SOD1
directly modulates chaperone activity, or even possesses
chaperone activity itself, as we did not detect an upregulation
of Hsp70 or Hsp40 protein levels by wtSOD1 (not shown).
The proposed chaperone depletion by the mutants would
match the widely assumed toxic gain of function of the SOD1
mutations.2–4 Due to the decreased capacity of motoneurons
to upregulate chaperones during/after cellular stress,31,32 the
net effect of mtSOD1 on chaperone activity could be negative
in motoneurons. In fact, the chaperone activity with
SODG93A expression was even below the control situation, in
accordance with decreased protein folding activities in
protein lysates from spinal cords of transgenic mice.11
However, at the current stage, we cannot exclude a loss of
function effect concerning the observed chaperone enhance-
ment by ALS-related mutations, and further work is required
to verify the observed inhibitory effect of SOD1 mutants
in motoneurons. In addition, the sum of mtSOD1 effects
on protein folding activity might also differ between
non-neuronal cell types. This could be of relevance as well,
as it was shown that SOD1-related motoneuron death is not
purely motoneuron-autonomous.33,34
Our observation that Hsp70 overexpression changed the
appearance of SOD1 aggregates – suggesting their dispersal
– further implies that increasing cellular chaperone activity
may be useful for ALS treatment. Consistent with this
hypothesis, overexpression of heat-shock proteins protected
against mtSOD1 toxicity in experiments using cell lines or
Figure 6 SOD1 ubiquitination positively correlates with Hsp70 binding in intact
single cells. FRET efficiencies of EGFP-SOD1/REACh-Hsp70 binding were plotted
against FRET efficiencies of EGFP-SOD1/REACh-ubiquitin experiments, and
revealed a high and linear correlation between both parameters (r¼ 0.97). Data
sets are presented as mean7S.E.M.
Figure 7 Overexpression of SOD1 alters cellular protein folding activity. The
genetically encoded chaperone activity sensor cdYFP (see text and Materials and
Methods section) was used to determine protein folding activity in intact single cells
upon SOD1 expression. Expression levels of the cdYFP reporter are normalized by
ratio imaging with the folding-independent HA immunostaining signal (Cy5-coupled
secondary antibody). (a) Shows representative cells with the normalized color-
coded chaperone activity during expression of the indicated SOD1 variants. In one
condition, ECFP-Hsp70 was coexpressed as a positive control. Respective
cumulative histograms are shown in (b). (c) Depicts the results of the quantitative
analysis (quantification of histograms performed as described in the figure legend
for Figure 2l, and the Materials and Methods section). Fluorescence intensities were
normalized to control cells expressing cdYFP only. SOD1 and Hsp70-ECFP
constructs were expressed for 16 h. In (d), protein folding activity under expression
of the different SOD1 species is correlated with Hsp70 binding (white symbols) or
ubiquitination (black symbols), respectively. PDF, probability distribution function
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primary motoneurons.6,12 However, overexpression of one
chaperone alone does not improve motoneuron survival in
in vivo ALS models,13, possibly because correction of further
cellular functions or the combined action of several different
chaperons may be required before motoneuronal apoptosis is
prevented in vivo. Indeed, treatment with arimoclomol, a
compound that leads to increased levels of both Hsp70 and
Hsp90 in the spinal cord, extended the lifespan of SOD1G93A-
transgenic mice.14
A technical caveat has to be mentioned, because the use of
fluorescent protein constructs, widely used for most cell
biological FRET experiments, generally implies the possibility
that the fluorescent tag alters the properties of the fused
protein. For example, the EGFP tag could reduce SOD1
copper loading by precluding the interaction with its copper
chaperone, or abolish the formation of physiological SOD1
dimers. SOD1 holoenzyme and demetallated, disulfide-
reduced SOD1 may be degraded by different pathways.29 A
potential shift in the cellular degradation pathway, for
example, from lysosomal to proteasomal or from ubiquitin-
dependent to ubiquitin-independent pathways, could then
result in alterations and impairment of the cytoplasmic
chaperone response. However, we showed that the EGFP-
SOD1 fusion proteins form homodimers and heterodimers
with endogenous untagged SOD1. Moreover, both dimers
exhibited the expected SOD activity, in accordance with the
robust enzymatic activity of previously published EGFP-
tagged SOD1 fusion constructs.35 Finally, we could demon-
strate the formation of the conserved intramolecular SOD1
disulfide bond in the fusion proteins. This indicates proper
processing by CCS, which inserts the catalytic copper
cofactor and catalyzes the formation of the conserved
disulfide bond.24 Substantial disruption of the physiological
maturation, function, and degradation of our EGFP-tagged
SOD1 fusion proteins is thus very unlikely. It is important to
note that whereas the physiological function of several other
mutant proteins related to neurodegenerative diseases, for
example, a-synuclein or APP, is not even known, the function
and maturation of fluorescent protein-SOD1 fusion constructs
can be verified.
In summary, we performed the first comprehensive FRET-
and biosensor-based study on SOD1 ubiquitination and
chaperone binding, as well as the activities of proteasomal
degradation and protein folding, demonstrating profound
differences between wt and mtSOD1. We show that central
facets of cellular ALS pathogenesis, specifically the interac-
tion of SOD1 with ubiquitin or chaperones, can be visualized in
intact single cells and quantified with spatial resolution. Our
results contribute to the understanding of mtSOD1 handling
and toxic action in neuronal cells, and introduce new
methodological avenues, in particular for the study of cell
biology in ALS.
Materials and Methods
Chemical reagents. Cell culture reagents were purchased from PAA
Laboratories. Lactacystin was obtained from Sigma-Aldrich (Co¨lbe, Germany).
Expression vectors. The cdYFP vector was produced by random
mutagenesis as described previously.21 EGFP-SOD1 constructs were cloned by
PCR amplification of the human wtSOD1 sequence and subsequent subcloning into
a pcDNA3.1 expression vector (Invitrogen, Carlsbad, USA) C-terminally of the
EGFP insert with KpnI/NotI. Respective SOD1 mutant expression vectors were
generated by PCR mutagenesis. The Pd2ECFP-N1 expression plasmid for PEST-
CFP (as proteasome activity sensor) and the EYFP expression vector were
purchased from Clontech (Mountain View, CA, USA). REACh and REACh-ubiquitin
expression constructs were described recently.20 REACh was cloned into the
multiple cloning site of the pcDNA3.1 expression vector after PCR amplification
using HindIII/BamHI. Rat Hsp70 was inserted C-terminally of REACh using
BamHI/EcoRI.
Cell culture and transfection. The rat nigrostriatal cell line CSM14.1,
immortalized by introduction of the temperature-sensitive simian virus 40 large T
antigen,36 was cultured in complete DMEM supplemented with 10% heat-
inactivated fetal calf serum, 100 U/ml penicillin G, and 100mg/ml streptomycin at
321C in 5% CO2. For transfection, cells were seeded on poly-L-ornithine/laminin
(Sigma, Co¨lbe, Germany)-coated coverslips (12 mm diameter) at a density of
15 000 cells/cm2. Cells were then incubated with Lipofectamine 2000 according to
the supplier’s protocol (Invitrogen, Carlsbad, USA) in serum-free medium containing
plasmid DNA. After 3 h, serum-containing medium was added and the cells were
incubated overnight. Finally, the transfection agent was replaced with medium
containing 10% fetal bovine serum. Cells were fixed in 4% paraformaldehyde (PFA)
in phosphate-buffered saline (PBS) for 15 min and covered with Vectashield
mounting medium at the indicated time points (see results section). The range of
transfection efficiency, as estimated by fluorescence microscopy, was
approximately 20–30%.
Cell death assay. Nuclei of fixed cells were DAPI stained and scored with a
microscope (Zeiss Axiovert) as normal or apoptotic (i.e., pyknotic or fragmented
nuclei). More than 200 transfected cells from at least three independent
experiments per condition were scored and values were calculated as
percentage of cells with apoptotic nuclei compared with the total cell count.
Fluorescence-based folding assay. Cells (CSM14.1 cells, see above)
were cotransfected with hemagglutinin (HA)-tagged cdYFP expression vector, and
respective pJRed-SOD1 expression vectors and were allowed to express the
proteins overnight (see section Cell culture and transfection). Cells were fixed with
4% PFA in PBS for 10 min, washed three times with PBS, and quenched for 10 min
with 50 mM Tris (pH 7.5)–100 mM NaCl. For the quantitation of folding efficiency,
cells expressing HA-cdYFP were subjected to anti-HA antibody
immunofluorescence analysis after permeabilization of fixed cells with 0.1%
Triton X-100 in PBS for 20 min. Cells were blocked with 5% bovine serum albumin in
PBS before incubation for 2 h with a 1 : 1000 dilution of the primary anti-HA
monoclonal antibody (Covance Research Products, Columbia, MO) and
subsequent incubation for 1 h with a 1 : 300 dilution of the Cy5-labeled goat anti-
mouse secondary antibody (Jackson Laboratories, Bar Harbor, Maine). Cells were
mounted in Mowiol. Three 5-min washes with PBS were performed between the
steps.
Detection of YFP and Cy5 fluorescence, image acquisition, and image arithmetic
were performed as previously described.21 Folding ratio frequency histograms were
analyzed with the Igor Pro analysis package (Wavemetrics Inc., Portland, OR).
Individual histograms were summed and cumulative histograms were normalized to
the integrated counts, that is, to the number of observed pixels per experimental
data set. For further analysis, see section Statistical analysis of FRET/folding
efficiency distributions below.
Proteasome assay. The Pd2ECFP-N1 expression vector (ECFP-PEST
vector) was purchased from Clontech (Mountain View, CA, USA). In this
construct, residues 422–461 of mouse ornithine decarboxylase (MODC) are
fused to the C-terminus of ECFP.26 This region contains a PEST amino-acid
sequence that targets the protein for degradation and results in rapid protein
turnover. ECFP-PEST has a half-life of approximately 2 h.26 In our experiments, the
ECFP-PEST vector was cotransfected with a conventional EYFP expression vector
to allow normalization of ECFP-PEST fluorescence to concentration differences
within (i.e., compartmentalization) and between (i.e., transfection efficiency) cells.
The image intensity values were corrected for the laser power setting needed to
obtain proper photon statistics under the various conditions. The linear calibration of
the laser power was verified by comparison of the fluorescence intensities of
fluorescent beads. The ratio images were masked by thresholding the fluorescence
intensities in the CFP or YFP channel to remove noise in the non-cellular
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background. Similar to the folding assay using cdYFP, the proteasomal function,
that is, normalized ECFP efficiency, was retrieved by simple image arithmetic
(ECFP fluorescence/YFP reference fluorescence) using ImageJ software (http://
rsb.info.nih.gov/ij/). The proteasomal function in cells coexpressing myc-SOD1
protein was then normalized to the cells expressing only ECFP and YFP (see
Results), so that the effects on proteasomal function were expressed in units of
native proteasomal function. Proteasomal function frequency histograms were
obtained from masked images of 10 cells for each condition, unless otherwise
indicated. Folding ratio frequency histograms were analyzed by the Igor Pro
analysis package. Normalized cumulative histograms were obtained and treated as
for the folding assay.
Fluorescence lifetime microscopy. Fluorescence time decays were
resolved by time-correlated single-photon counting (TCSPC) using an SPC830
acquisition board (Becker & Hickl, Berlin). Two-photon excitation of GFP was
performed at 900 nm by a femtosecond mode-locked (76 MHz repetition rate)
Ti:Sapphire Mira900F laser pumped by a Verdi-V8 laser (both from Coherent, Santa
Clara, USA). The laser beam was fed to the scanning head of a Leica TSC-SP2-
AOBS confocal microscope. Fluorescence was collected on a multichannel plate
photomultiplier (R3809U-50; Hamamatsu Photonics, Hamamatsu City, Japan)
through a bandpass GFP filter at 515730 nm (EGFP-HQset by Analysentechnik,
Lagenfeld, Germany). The fluorescence transients were acquired using SPCIMAGE
software (Becker & Hickl), exported, and analyzed using an in-house-developed
MATLAB (MathWorks, Natick, MA) toolbox. Images were acquired in 512 512-
pixel format, collecting in excess of 1000 photons per pixel in 5–10 min.
SOD1 ubiquitination was imaged in CSM14.1 cells expressing EGFP or EGFP-
wt/mtSOD1 (pcDNA3.1 expression vector; Clontech) and REACh-ubiquitin
constructs. Binding of Hsp70 to wt/mtSOD1 was imaged in CSM14.1 cells
expressing EGFP-wt/mtSOD1 and REACh–Hsp70 (see also section Expression
vectors). Cells were transiently transfected and fixed with 4% PFA in PBS 18 h after
transfection (see above).
Image processing. Histograms from (cdYFP) folding responses were further
processed using the Igor Pro package. Control histograms for cells that did not
express SOD1 proteins were used to rescale the ratio values to folding efficiencies,
that is, the average ratio was set to 1 to represent the base folding efficiency in
control cells. The folding efficiency distributions of individual cells were normalized
to an integrated value of unity. Individual normalized histograms for all cells within
one condition were cumulated and renormalized to unity to compensate for different
sample sizes.
Images of the CFP-PEST degradation assay were processed using the same
procedure.
Similarly, distribution histograms were obtained from lifetime images of SOD1
ubiquitination and Hsp70 interaction experiments. Here, the lifetimes (t) were
converted to FRET efficiencies by comparison with the EGFP lifetime of cells
expressing EGFP-SOD1 in the absence of REACh-labeled interaction partner (tr)
according to: FRET¼ 1(t/tr). Proteasomes were defined as peri-nuclear
punctate structures with high FRET between EGFP-SOD1 and REACh-ubiquitin
and were segmented for processing by thresholding of the FRET efficiencies.
Statistical analysis of FRET/folding efficiency distributions. As
the normalized histograms represent probability distribution functions, they can be
used to estimate the probability of obtaining significant FRET on a cell-by-cell basis.
Comparison of these results within one sample then provides the statistical values
(average7standard error of the mean) and significance.
The cumulative distribution of the FRET efficiencies of control cells expressing
EGFP-SOD1 without coexpression of the REACh-labeled Hsp70 or ubiquitin were
fitted with a Gaussian function to obtain the average plus three times standard
deviation value (3s), which amounted to 14% of FRET. Any values exceeding this
threshold thus represent increases that significantly deviate from the control
situation. The probability of obtaining significant FRET can be derived for each cell
by integration of the normalized FRET distribution histograms above the 3s
threshold. The results for all cells within one sample were subjected to one-way
ANOVA with Tukey’s post-testing to evaluate the statistical significance of the
average results.
SOD1 activity assay. The SOD1 activity assay was performed as described
previously.22 Briefly, CSM14.1 cells were lysed in ddH2O by three freeze–thaw
cycles, and lysates were clarified by centrifugation at 16 100 g for 10 min at 41C.
Samples (20mg per lane) were loaded in native buffer and separated using 7.5%
non-denaturing polyacrylamide gels. Gels were then soaked in 2.45 mM nitro blue
tetrazolium (NBT) solution for 20 min, followed by incubation in developer solution
for 15 min (28 mM TEMED, 28mM riboflavin, 36 mM KH2PO4) at room temperature
in the dark. Gels were then illuminated for 15 min until sufficient contrast between
achromatic zones (dismutase activity) and blue background was achieved. Human
wtSOD1 protein purified from erythrocytes (Sigma-Aldrich, Co¨lbe, Germany) was
used as positive control.
AMS reaction disulfide assay. The thiol-specific reagent 4-acetamide-40-
maleimidylstilbene-2,20-disulfonic acid (AMS) was used to determine the extent of
disulfide bond formation in SOD1-EGFP, following the protocol described by Jensen
and Culotta,37 with minor variations. Briefly, cells expressing SOD1-EGFP were
lysed in a buffer containing 6 M guanidine–HCl, 50 mM Tris pH 8.3, 3 mM EDTA,
1 mM bathocuproin sulfonate (BCS), and 0.5 % Triton X-100. Lysates were
sonicated and centrifuged to remove cellular debris. The supernatants were
incubated in the presence of 1 mM dithiothreitol (DTT) for 30 min (to reduce disulfide
bonds), followed by incubation with 15 mM AMS for 60 min at 371C, or incubated
only with AMS under oxygen-free conditions. Protein lysates were precipitated to
remove unreacted DTT and AMS, solubilized in loading buffer without reducing
agents, and subjected to SDS-PAGE on a gradient gel.
Western blot analysis. Western blot analysis was performed using EGFP-
SOD1-transfected CSM14.1 cells homogenized in lysis buffer containing 50 mM
Tris-HCl; 150 mM NaCl; 1% Triton-X 100; 0.1 mM PMSF; and 2 lml/ml pepstatin,
leupeptin, and aprotinin, pH 8.3. Lysates were centrifuged at 16 100 g and the
protein concentration of the supernatant was determined using the BCA reagent
(Pierce, Rockford, IL). After separating the lysates by reducing SDS-PAGE (10%
gel, 20 g protein per lane), proteins were transferred to polyvinylidene difluoride
(PVDF) membrane and blocked in 5% skimmed milk in PBS-T (0.1% Tween 20).
Proteins were detected by incubation with primary antibodies directed against
SOD1 (SOD-100; Stressgen, Victoria, Canada). Primary antibody was visualized by
incubation with respective HRP-conjugated secondary antibodies (Dianova,
Hamburg, Germany). Lysates from at least three different experiments were tested.
Statistical analysis. All values are expressed as mean7S.E.M. ANOVA
followed by Tukey’s post-testing was used to determine significance, unless
otherwise indicated (NCSS Software; NCSS, Kaysville, USA).
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